What Researchers Did
This review article summarized current knowledge on carbon monoxide (CO) poisoning, its effects on the body, and the role of hyperbaric oxygen therapy (HBOT).
What They Found
Each year, 50,000 people in the United States visit emergency departments for CO poisoning. The review found that hyperbaric oxygen (HBO2) hastens the removal of carbon monoxide from the blood and positively affects inflammation and brain injury caused by CO poisoning. It also noted that HBO2 is supported by three human randomized clinical trials and animal studies for all cases of acute symptomatic CO poisoning.
What This Means for Canadian Patients
For Canadian patients experiencing acute symptomatic carbon monoxide poisoning, this review suggests that hyperbaric oxygen therapy should be considered as a treatment option. HBOT may help reduce the severe neurological and other health problems often associated with CO poisoning by addressing its effects on the body.
Canadian Relevance
This study covers carbon monoxide poisoning, which is a Health Canada-recognized indication for hyperbaric oxygen therapy. No direct Canadian connection or authors were identified.
Study Limitations
As a review article, this study synthesizes existing research rather than presenting new primary data or clinical trials.